Literature DB >> 35410184

The local burden of disease during the first wave of the COVID-19 epidemic in England: estimation using different data sources from changing surveillance practices.

Emily S Nightingale1,2, Sam Abbott3,4, Timothy W Russell3,4, Rachel Lowe3,5,6,7, Graham F Medley8,3, Oliver J Brady3,4.   

Abstract

BACKGROUND: The COVID-19 epidemic has differentially impacted communities across England, with regional variation in rates of confirmed cases, hospitalisations and deaths. Measurement of this burden changed substantially over the first months, as surveillance was expanded to accommodate the escalating epidemic. Laboratory confirmation was initially restricted to clinical need ("pillar 1") before expanding to community-wide symptomatics ("pillar 2"). This study aimed to ascertain whether inconsistent measurement of case data resulting from varying testing coverage could be reconciled by drawing inference from COVID-19-related deaths.
METHODS: We fit a Bayesian spatio-temporal model to weekly COVID-19-related deaths per local authority (LTLA) throughout the first wave (1 January 2020-30 June 2020), adjusting for the local epidemic timing and the age, deprivation and ethnic composition of its population. We combined predictions from this model with case data under community-wide, symptomatic testing and infection prevalence estimates from the ONS infection survey, to infer the likely trajectory of infections implied by the deaths in each LTLA.
RESULTS: A model including temporally- and spatially-correlated random effects was found to best accommodate the observed variation in COVID-19-related deaths, after accounting for local population characteristics. Predicted case counts under community-wide symptomatic testing suggest a total of 275,000-420,000 cases over the first wave - a median of over 100,000 additional to the total confirmed in practice under varying testing coverage. This translates to a peak incidence of around 200,000 total infections per week across England. The extent to which estimated total infections are reflected in confirmed case counts was found to vary substantially across LTLAs, ranging from 7% in Leicester to 96% in Gloucester with a median of 23%.
CONCLUSIONS: Limitations in testing capacity biased the observed trajectory of COVID-19 infections throughout the first wave. Basing inference on COVID-19-related mortality and higher-coverage testing later in the time period, we could explore the extent of this bias more explicitly. Evidence points towards substantial under-representation of initial growth and peak magnitude of infections nationally, to which different parts of the country contribute unequally.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35410184      PMCID: PMC8996221          DOI: 10.1186/s12889-022-13069-0

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   4.135


  13 in total

Review 1.  Random walk models in biology.

Authors:  Edward A Codling; Michael J Plank; Simon Benhamou
Journal:  J R Soc Interface       Date:  2008-08-06       Impact factor: 4.118

2.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.

Authors:  Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

3.  Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales.

Authors:  Mark D Verhagen; David M Brazel; Jennifer Beam Dowd; Ilya Kashnitsky; Melinda C Mills
Journal:  BMC Med       Date:  2020-06-29       Impact factor: 8.775

Review 4.  Impact of sex and gender on COVID-19 outcomes in Europe.

Authors:  Catherine Gebhard; Vera Regitz-Zagrosek; Hannelore K Neuhauser; Rosemary Morgan; Sabra L Klein
Journal:  Biol Sex Differ       Date:  2020-05-25       Impact factor: 5.027

5.  Sex differences in COVID-19 case fatality: do we know enough?

Authors:  Nabamallika Dehingia; Anita Raj
Journal:  Lancet Glob Health       Date:  2020-11-05       Impact factor: 26.763

6.  Modelling and predicting the spatio-temporal spread of COVID-19, associated deaths and impact of key risk factors in England.

Authors:  B Sartorius; A B Lawson; R L Pullan
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

7.  Dynamics of the COVID-19 epidemic in urban and rural areas in the United States.

Authors:  Diego F Cuadros; Adam J Branscum; Zindoga Mukandavire; F DeWolfe Miller; Neil MacKinnon
Journal:  Ann Epidemiol       Date:  2021-04-22       Impact factor: 3.797

8.  Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections.

Authors:  Timothy W Russell; Nick Golding; Joel Hellewell; Sam Abbott; Lawrence Wright; Carl A B Pearson; Kevin van Zandvoort; Christopher I Jarvis; Hamish Gibbs; Yang Liu; Rosalind M Eggo; W John Edmunds; Adam J Kucharski
Journal:  BMC Med       Date:  2020-10-22       Impact factor: 8.775

9.  Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.

Authors:  Hannah Peckham; Nina M de Gruijter; Charles Raine; Anna Radziszewska; Coziana Ciurtin; Lucy R Wedderburn; Elizabeth C Rosser; Kate Webb; Claire T Deakin
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 17.694

10.  Inferring the number of COVID-19 cases from recently reported deaths.

Authors:  Thibaut Jombart; Kevin van Zandvoort; Timothy W Russell; Christopher I Jarvis; Amy Gimma; Sam Abbott; Sam Clifford; Sebastian Funk; Hamish Gibbs; Yang Liu; Carl A B Pearson; Nikos I Bosse; Rosalind M Eggo; Adam J Kucharski; W John Edmunds
Journal:  Wellcome Open Res       Date:  2020-04-27
View more
  1 in total

1.  Correction: The local burden of disease during the first wave of the COVID-19 epidemic in England: estimation using different data sources from changing surveillance practices.

Authors:  Emily S Nightingale; Sam Abbott; Timothy W Russell; Rachel Lowe; Graham F Medley; Oliver J Brady
Journal:  BMC Public Health       Date:  2022-06-07       Impact factor: 4.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.